No Data
TD Cowen Maintains TransMedics(TMDX.US) With Buy Rating, Maintains Target Price $175
Promising Outlook and Attractive Entry Point: Josh Jennings' Buy Rating on TransMedics Group
Analysts Conflicted on These Healthcare Names: TransMedics Group (TMDX), Collegium Pharmaceutical (COLL) and Korro Bio (KRRO)
Earnings Preview: TransMedics to Report Financial Results Post-market on October 28
With A 25% Price Drop For TransMedics Group, Inc. (NASDAQ:TMDX) You'll Still Get What You Pay For
TransMedics Group (TMDX) Prepare for a Potential Rally as Elliott Wave Signals a Bullish Move
sociable Dingo_8604 : Well said @Brianjh
I totally agree with all the above especially 1, 5, 6 & 8. They resonate with me and my thoughts. I need to save this post
KK1989 : Thank you for the reminder.
103383658 : good read!
scarlight : it is not ok to lose money. This is a terrifying advice.
102747798 : Bravo. Well said.
Thanks for sharing your thoughts.
I can resonate with some of the points.
Wish you the best!
View more comments...